Home Biosimilar Antibodies Others Others null Romosozumab(anti-sclerostin) For research use only.
Not for use in humans.

Romosozumab(anti-sclerostin)

Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug, that simultaneously increases bone formation and decreases bone resorption.

Romosozumab(anti-sclerostin)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 19.88mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug, that simultaneously increases bone formation and decreases bone resorption.

Product Details

CAS No. 909395-70-6
Molecular Weight 150 kDa
Isotype human IGg2, κ
Application Romosozumab(anti-sclerostin)
Purification Protein G
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20 mM Arg, pH 5.0
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Romosozumab(anti-sclerostin) | Romosozumab(anti-sclerostin) supplier | purchase Romosozumab(anti-sclerostin) | Romosozumab(anti-sclerostin) cost | Romosozumab(anti-sclerostin) manufacturer | order Romosozumab(anti-sclerostin) | Romosozumab(anti-sclerostin) distributor